Semaglutide Not Linked to Increased Risk of Eye Disorders, Diabetic Retinopathy

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

MONDAY, Aug. 18, 2025 -- For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy, according to a review published online Aug. 14 in JAMA Ophthalmology.

Gabriella R. Natividade, M.D., from the Universidade Federal do Rio Grande do Sul in Porto Alegre, Brazil, and colleagues examined the incidence of eye disorders, diabetic retinopathy, and nonarteritic anterior ischemic optic neuropathy (NAION) in adults treated with semaglutide in a systematic review and meta-analysis. Data were included from 78 trials with 73,640 participants.

The researchers found that the risk of eye disorders or diabetic retinopathy was not increased or reduced with semaglutide. However, semaglutide treatment was associated with a significantly increased risk of NAION (odds ratio, 3.92). The risk of bias was low overall. The sample size was sufficient to avoid missing alternative results for diabetic retinopathy but not for NAION, based on evidence provided by trial sequential analysis.

"Treatment with semaglutide in adults was not associated with an increased risk of eye disorders or diabetic retinopathy in this study, and future studies are unlikely to change these results," the authors write. "Additional studies dedicated to checking the relationship between semaglutide and NAION are needed."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-19 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords